CorriXR Therapeutics, Inc., an oncology-focused biotherapeutics company pioneering a novel gene editing platform to overcome drug resistance in solid tumors, today announced the publication of a ...

A quiet hope has started to grow among people living with stubborn cholesterol problems as researchers report early success ...

Generation LNP Advancements enhance potency and safety, expand delivery beyond the liver, and enable broader therapeutic ...

Detailed price information for Prime Medicine Inc (PRME-Q) from The Globe and Mail including charting and trades.

Students at Weill Cornell Medicine-Qatar (WCM-Q) gained valuable experience of biomedical research during the summer recess ...